Lyons Wealth Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Lyons Wealth Management’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-21,515	Closed	-$365K	–	75
2014 Q4	$365K	Sell	21,515 -11,825	-35%	-$166K	0.38%	40
2014 Q3	$398K	Hold	33,340	–	–	0.42%	46
2014 Q2	$187K	Buy	33,340 +4,000	+14%	+$18.4K	0.17%	65
2014 Q1	$108K	Buy	29,340 +4,000	+16%	+$15.2K	0.09%	61
2013 Q4	$86K	Hold	25,340	–	–	0.08%	56
2013 Q3	$107K	Hold	25,340	–	–	0.1%	66
2013 Q2	$116K	Buy	+25,340	New	+$87.1K	0.12%	64

Lyons Wealth Management's AVNR Position: Q1 2015 in Review

Lyons Wealth Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 21,515 shares — an estimated $365K sold.

Lyons Wealth Management first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $398K in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Lyons Wealth Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Lyons Wealth Management sold 21,515 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $365K.
Lyons Wealth Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
Lyons Wealth Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $398K in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Lyons Wealth Management's 13F filing for Q1 2015, filed 13 May 2015.